Mike R Loken

6PUBLICATIONS
61CO-AUTHORS
Haematological tumoursGene and molecular therapyHaematologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 24, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.

|May 21, 2025
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.

Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena

|Apr 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Benjamin J Huang, Lauren K Meyer, Todd A Alonzo

|Mar 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.

Jessica A Pollard, Todd A Alonzo, Robert Gerbing

|Dec 02, 2021
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Adam J Lamble, Lisa Eidenschink Brodersen, Todd A Alonzo

|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.

Jessica A Pollard, Erin Guest, Todd A Alonzo

Pageof 1

Frequent Collaborators

5 joint publications

Richard Aplenc

4 joint publications

Edward Anders Kolb

3 joint publications

Lisa Eidenschink Brodersen

3 joint publications

Alan S Gamis